ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development and validation of an MRI-based nomogram for the preoperative prediction of tumor mutational burden in lower-grade gliomas

Liu, En-Tao; Zhou, Shuqin; Li, Yingwen; Zhang, Siwei; Ma, Zelan; Guo, Junbiao; Guo, Lei; Zhang, Yue; Guo, Quanlai; Xu, Li*广东省人民医院; 广州中医药大学
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY2022-3DOI: 10.21037/qims-21-300
4被引5阅读
引用收藏
分享

摘要

Background: High tumor mutational burden (TMB) is an emerging biomarker of sensitivity to immune checkpoint inhibitors. In this study, we aimed to determine the value of magnetic resonance (MR)-based preoperative nomogram in predicting TMB status in lower-grade glioma (LGG) patients. @@@ Methods: Overall survival (OS) data were derived from The Cancer Genome Atlas (TCGA) and then analyzed by using the Kaplan-Meier method and time-dependent receiver operating characteristic (tdROC) analysis. The magnetic resonance imaging (MRI) data of 168 subjects obtained from The Cancer Imaging Archive (TCIA) were retrospectively analyzed. The correlation was explored by univariate and multivariate regression analyses. Finally, we performed tenfold cross validation. TMP values were retrieved from the supplementary information of a previously published article. @@@ Results: The high TMB subtype was associated with the shortest median OS (high vs. low: 50.9 vs. 95.6 months, P<0.05). The tdROC for the high-TMB tumors was 74% (95% CI: 61-86%) for survival at 12 months, and 71% (95% CI: 60-82%) for survival at 24 months. Multivariate logistic regression analysis confirmed that three risk factors [extranodular growth: odds ratio (OR): 8.367, 95% CI: 3.153-22.199, P<0.01; length-width ratio median: OR: 1.947, 95% CI: 1.025-3.697, P<0.05; frontal lobe: OR: 0.455, 95% CI: 0.229-0.903, P<0.05] were significant independent predictors of high-TMB tumors. The nomogram showed good calibration and discrimination. This model had an area under the curve (AUC) of 0.736 (95% CI: 0.655-0.817). Decision curve analysis (DCA) demonstrated that the nomogram was clinically useful. The average accuracy of the tenfold cross validation was 71.6% for high-TMB tumors. @@@ Conclusions: Our results indicated that a distinct OS disadvantage was associated with the high TMB group. In addition, extranodular growth, nonfrontal lobe tumors and length-width ratio median can be conveniently used to facilitate the prediction of high-FMB tumors.

学科与关键词

关键词
Nomogramgliomaradiogenomicstumor mutational burden
相关
加载中…
  • Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study
    Zhang, Hongbo; Zhang, Hanwen; Zhang, Yuze; Zhou, Beibei; Wu, Lei; Yang, Wanqun; Lei, Yi*; Huang, Biao*Neuroradiology, 2024, 66(1): 81-92.
  • Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach
    Cao, Mengqiu; Suo, Shiteng; Zhang, Xiao; Wang, Xiaoqing; Xu, Jianrong; Yang, Wei*; Zhou, Yan*Biomed Research International, 2021, 2021: 1235314.被引 3
  • Radiomic Analysis of ContrastEnhanced MRI Predicts DNA CopyNumber Subtype and Outcome in Lower-Grade Gliomas
    Wan, Yun; Zhou, Shuqin; Zhang, Ying; Deng, Xianqin; Xu, Li*ACADEMIC RADIOLOGY, 2022, 29(9): E189-E196.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY
发表日期
2022-03
卷期
第 12 卷, 第 3 期
页码
1684-1697
DOI
10.21037/qims-21-300
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81801688]; Traditional Chinese Medicine Bureau of Guangdong Province [20181116]

作者

  • L

    Liu, En-Tao (第一作者)

    guangdong prov peoples hosp

  • Z

    Zhou, Shuqin

    2 · guangzhou univ chinese med · guangdong prov hosp

查看全部 10 位作者收起作者
  • L

    Li, Yingwen

    2 · guangzhou univ chinese med · guangdong prov hosp

  • Z

    Zhang, Siwei

    2 · guangzhou univ chinese med · guangdong prov hosp

  • M

    Ma, Zelan

    2 · guangzhou univ chinese med · guangdong prov hosp

  • G

    Guo, Junbiao

    2 · guangzhou univ chinese med · guangdong prov hosp

  • G

    Guo, Lei

    2 · guangzhou univ chinese med · guangdong prov hosp

  • Z

    Zhang, Yue

    2 · guangzhou univ chinese med · guangdong prov hosp

  • G

    Guo, Quanlai

    2 · guangzhou univ chinese med · guangdong prov hosp

  • X

    Xu, Li (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417